| Q27694705 | A human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate site |
| Q34978574 | Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress |
| Q33637485 | Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation |
| Q35921527 | Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis. |
| Q89114866 | De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancer |
| Q34182803 | Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis |
| Q37190403 | Dephosphorylation and mitochondrial translocation of cofilin sensitizes human leukemia cells to cerulenin-induced apoptosis via the ROCK1/Akt/JNK signaling pathway |
| Q36177509 | Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development |
| Q35765259 | Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. |
| Q91996647 | Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia |
| Q36691586 | Fatty acid synthase is a novel therapeutic target in multiple myeloma |
| Q33421665 | Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer |
| Q40232827 | Fatty acid synthase: a novel target for antiglioma therapy |
| Q38194070 | Glucose and glutamine metabolism control by APC and SCF during the G1-to-S phase transition of the cell cycle. |
| Q24561962 | Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells |
| Q39939206 | Inhibition of fatty-acid synthase induces caspase-8-mediated tumor cell apoptosis by up-regulating DDIT4. |
| Q37665432 | Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase |
| Q34779246 | Lipoprotein lipase links dietary fat to solid tumor cell proliferation. |
| Q36062114 | Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b |
| Q36896218 | Natural compounds as regulators of the cancer cell metabolism |
| Q42494524 | Overexpression of fatty acid synthase in human urinary bladder cancer and combined expression of the synthase and Ki-67 as a predictor of prognosis of cancer patients |
| Q33561797 | Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction |
| Q55352576 | Prediction of acute GVHD and relapse by metabolic biomarkers after allogeneic hematopoietic stem cell transplantation. |
| Q33640702 | Quantitative proteomic analysis reveals the perturbation of multiple cellular pathways in HL-60 cells induced by arsenite treatment |
| Q28472927 | Saturated fatty acids modulate cell response to DNA damage: implication for their role in tumorigenesis |
| Q34431003 | Subcutaneous adipocytes promote melanoma cell growth by activating the Akt signaling pathway: role of palmitic acid |
| Q35112277 | Synthesis and antitumor activity of an inhibitor of fatty acid synthase |
| Q55316125 | Tachyplesin Causes Membrane Instability That Kills Multidrug-Resistant Bacteria by Inhibiting the 3-Ketoacyl Carrier Protein Reductase FabG. |
| Q38792334 | Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions |
| Q84434166 | The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells |
| Q26997789 | The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer |
| Q36508749 | ras-Induced up-regulation of CTP:phosphocholine cytidylyltransferase α contributes to malignant transformation of intestinal epithelial cells. |